Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 2.79 is 126% above its 5-year average of -10.73, near the high end of its 5-year range (-50.46–2.79).
306.67% above its 12-month average of -1.35.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.44.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:28:43.875Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
2.79
EARNINGS PER SHARE (EPS) AVG TTM
-1.35
EARNINGS PER SHARE (EPS) AVG 3Y
-2.70
EARNINGS PER SHARE (EPS) AVG 5Y
-10.73
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+306.67%
CURRENT VS 3Y AVG
+203.33%
CURRENT VS 5Y AVG
+125.99%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Q32 Bio Inc.
Market Cap
$241.39M
Earnings Per Share (EPS)
2.79
TTM Avg
-1.35
3Y Avg
-2.70
5Y Avg
-10.73
Market Cap
$241.34M
Earnings Per Share (EPS)
-0.46
TTM Avg
-0.61
3Y Avg
-0.71
5Y Avg
-1.81
Market Cap
$241.94M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.09
3Y Avg
-1.28
5Y Avg
-1.70
Market Cap
$239.02M
Earnings Per Share (EPS)
-1.04
TTM Avg
-0.86
3Y Avg
-1.57
5Y Avg
-1.50
Market Cap
$239.01M
Earnings Per Share (EPS)
-0.28
TTM Avg
-0.24
3Y Avg
-0.42
5Y Avg
-0.45
Market Cap
$237.57M
Earnings Per Share (EPS)
-0.39
TTM Avg
-0.86
3Y Avg
-1.43
5Y Avg
-1.56
Market Cap
$236.82M
Earnings Per Share (EPS)
-2.38
TTM Avg
-2.11
3Y Avg
-1.81
5Y Avg
-1.81
Market Cap
$235.97M
Earnings Per Share (EPS)
-0.04
TTM Avg
0.58
3Y Avg
0.64
5Y Avg
0.70
Market Cap
$235.66M
Earnings Per Share (EPS)
-0.11
TTM Avg
-0.18
3Y Avg
-0.30
5Y Avg
-0.87
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Q32 Bio Inc. (QTTB) | $241.39M | 2.79 | -1.35 | -2.70 | -10.73 |
| Quantum-Si incorporated (QSI)vs › | $241.34M | -0.46 | -0.61 | -0.71 | -1.81 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | N/A | -1.09 | -1.28 | -1.70 |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | -1.04 | -0.86 | -1.57 | -1.50 |
| High Tide Inc. (HITI)vs › | $239.01M | -0.28 | -0.24 | -0.42 | -0.45 |
| Invivyd, Inc. (IVVD)vs › | $237.57M | -0.39 | -0.86 | -1.43 | -1.56 |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | -2.38 | -2.11 | -1.81 | -1.81 |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | -0.04 | 0.58 | 0.64 | 0.70 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | -0.11 | -0.18 | -0.30 | -0.87 |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $247.27M | -5.64 | -3.00 | -4.16 | -2.76 |
Trailing EPS (TTM)
$2.79
Forward EPS (Est.)
$-1.49
P/E Ratio
2.9
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 2.42 |
| 2024-12-31 | -5.12 |
| 2023-12-31 | -4.51 |
| 2022-12-31 | -3.59 |
| 2021-12-31 | -3.15 |
| 2020-12-31 | -50.46 |
| 2019-12-31 | -44.41 |
| 2018-12-31 | -35.04 |
| 2017-12-31 | -14.42 |
| 2016-12-31 | -3.87 |
